Prelude Therapeutics Inc. (PRLD) Social Stream
PRELUDE THERAPEUTICS INC (PRLD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRLD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 4 | $62 | $33 | $45.5 | $4.03 | 1029.03% |
| 2021-11-17 | 4 | $62 | $20 | $42.25 | $4.03 | 948.39% |
| 2022-01-06 | 4 | $62 | $20 | $41.75 | $4.03 | 935.98% |
| 2022-01-31 | 4 | $62 | $20 | $38 | $4.03 | 842.93% |
| 2022-02-28 | 4 | $62 | $12 | $36 | $4.03 | 793.3% |
| 2022-03-15 | 4 | $62 | $10 | $26 | $4.03 | 545.16% |
| 2022-03-17 | 4 | $62 | $10 | $25.75 | $4.03 | 538.96% |
| 2022-05-10 | 4 | $62 | $9 | $25.5 | $4.03 | 532.75% |
| 2022-05-12 | 4 | $19 | $9 | $14 | $4.03 | 247.39% |
| 2022-05-27 | 5 | $19 | $7 | $13.5 | $4.03 | 234.99% |
| 2022-08-13 | 5 | $19 | $7 | $12.6 | $4.03 | 212.66% |
| 2022-11-14 | 5 | $16 | $8 | $11.2 | $4.03 | 177.92% |
| 2022-11-17 | 5 | $15 | $8 | $11 | $4.03 | 172.95% |
| 2023-02-08 | 5 | $15 | $6 | $10.6 | $4.03 | 163.03% |
| 2023-03-16 | 4 | $15 | $6 | $10.25 | $4.03 | 154.34% |
| 2023-08-04 | 4 | $17 | $5 | $10.5 | $4.03 | 160.55% |
| 2023-08-17 | 5 | $17 | $5 | $9.6 | $4.03 | 138.21% |
| 2023-09-26 | 5 | $17 | $5 | $9.4 | $4.03 | 133.25% |
| 2023-10-20 | 5 | $10 | $2 | $6.6 | $4.03 | 63.77% |
| 2023-11-03 | 5 | $10 | $2 | $6.2 | $4.03 | 53.85% |
| 2023-11-07 | 5 | $10 | $2 | $6 | $4.03 | 48.88% |
| 2023-12-19 | 5 | $10 | $2 | $4.8 | $4.03 | 19.11% |
The Trend in the Analyst Price Target
PRLD's average price target has moved down $31.2 over the prior 22 months.
Over the past 47 weeks, PRLD's average upside potential has been 120.38%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 5 | 15 | 6 | 10.25 | 6.37 | 60.91% |
| 2023-04-12 | 4 | 17 | 6 | 10.75 | 7.68 | 39.97% |
| 2023-05-08 | 4 | 17 | 6 | 10.75 | 6.37 | 68.76% |
| 2023-08-04 | 4 | 17 | 5 | 9.40 | 3.67 | 156.13% |
| 2023-10-19 | 5 | 10 | 2 | 6.60 | 2.32 | 184.48% |
PRLD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.54 | 2 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 23 months, PRLD's average broker recommendation rating worsened by 1.35.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, PRELUDE THERAPEUTICS INC's variance in analysts' estimates is lower than -2470.65% of them.
- In terms of how PRELUDE THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2525.74% of that group.
- In the context of stocks in the mid market cap category, PRELUDE THERAPEUTICS INC's number of analysts covering the stock is greater than 474.99% of them.
- In the context of stocks in the mid market cap category, PRELUDE THERAPEUTICS INC's average analyst price target is greater than 696.8% of them.
In the Pharmaceutical Products industry, PMVP, ME, and STTK are the three stocks most similar to PRELUDE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PRLD a Buy, Hold or Sell? See the POWR Ratings now!